Who is sponsoring NCT03879304?

NCT03879304 is sponsored by University of Malaga.

What drugs are being tested in NCT03879304?

Interventions in NCT03879304: multimodal physiotherapy program with RV, traditional physiotherapy program.

What condition does NCT03879304 study?

NCT03879304 studies Muscular Dystrophy, Duchenne and Becker Types.

Is NCT03879304 still recruiting?

NCT03879304 is currently completed. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT03879304: RVDuchenne

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.

Completed NA Last updated 13 May 2024

What this trial tests

NA trial testing multimodal physiotherapy program with RV in Muscular Dystrophy, Duchenne and Becker Types in 12 participants. Completed in 11 March 2023.

Timeline

15 March 2021

Primary endpoint
30 October 2022

11 March 2023

Quick facts

Lead sponsor	University of Malaga
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	12
Start date	15 March 2021
Primary completion	30 October 2022
Estimated completion	11 March 2023
Sites	1 location across Spain

Drugs / interventions tested

multimodal physiotherapy program with RV
traditional physiotherapy program

Conditions studied

Muscular Dystrophy, Duchenne and Becker Types — all drugs for Muscular Dystrophy, Duchenne and Becker Types →

Sponsor

University of Malaga

Who can join

Adults 4 to 15, any sex, with Muscular Dystrophy, Duchenne and Becker Types. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Duchenne's Muscular Dystrophy and Becker Dystrophy, hereafter DMD and BMD, is a serious and progressive disease that affects 1 in 3,500-6,000 males born alive. Scale 6-minute walking test, is used for determine the inclusion of children with DMD in pharmacological studies. Furthemore, is used to verify a training effectiveness assessing muscular endurance and cardio-respiratory functions. This Research evaluates the feasibility and effectiveness of a multimodal physiotherapist program with virtual reality glasses.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Non-Invasive Respiratory Assessment in Duchenne Muscular Dystrophy: From Clinical Research to Outcome Measures.
Pennati F, LoMauro A, D'Angelo MG, Aliverti A. · · 2021 · cited 14× · PMID 34575096 · DOI 10.3390/life11090947
Effectiveness of a 5-Week Virtual Reality Telerehabilitation Program for Children With Duchenne and Becker Muscular Dystrophy: Prospective Quasi-Experimental Study.
Baeza-Barragán MR, Labajos Manzanares MT, Amaya-Álvarez MC, Morales Vega F, et al · · 2023 · cited 5× · PMID 37990809 · DOI 10.2196/48022

Verify or expand the search:

Other University of Malaga trials

Trials by the same sponsor.

NCT07472205 — Foot and Ankle Strengthening Program to Improve Physical Function in Menopausal Women · NA · not yet recruiting
NCT07408622 — Virtual Reality Therapy for Wrist and Hand Injury Recovery · NA · not yet recruiting
NCT07428304 — Cortical Changes After Upper Limb Immobilization Measured by Electroencephalography · not yet recruiting
NCT07371715 — Home-Based Auricular Transcutaneous Vagus Nerve Stimulation (tVNS) for Sleep Quality and Psycho-Academic Outcomes in Hea · NA · not yet recruiting
NCT06438666 — Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children Wit · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03879304 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Malaga
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03879304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing